The global powered surgical instrument market was pegged at $1.94 billion in 2017 and is expected to garner $2.73 billion by 2025, registering a CAGR of 4.2% through 2025.
High prevalence of chronic diseases and rise in geriatric population drive the growth of the global powered surgical instrument market. However, inadequate quality assurance and lack of proper sterilization practices hamper the market growth. On the contrary, increasing healthcare expenditure is expected to create lucrative opportunities for the market players in the coming years.
Based on application, the market is segmented into neurosurgery, plastic surgery, ENT surgery, cardiovascular surgery, cardiothoracic surgery and others. The orthopedic surgery segment contributed to the major revenue in 2017 and is anticipated to continue its leadership status during the forecast period. The growing demand of minimally invasive surgery in orthopedics and increase in geriatric population augment the demand of powered surgical instruments.By region, North America is anticipated to maintain its dominance during the forecast period due to cutting-edge healthcare infrastructure and high adoption rate of innovative surgical tools.
Battery-powered instruments segment tportray fastest growth through 2025
The battery-powered instruments segment is expected to register the fastest CAGR of 4.7% during the forecast period. This is attributed to the fact that battery-powered instruments are coreless, lightweight, efficient, and chargeable that provide comfort during surgery, which have boosted their demand. However, electric instruments segment held the largest share in the market in 2017, contributing about 41% of the total revenue, owing to the low cost of electric surgical handpieces and higher power output compared to pneumatic and battery-powered instruments. Pneumatic instruments segment would exhibit steady growth during the forecast period.
North America governs the market in 2017
North America held the largest share in the global powered surgical instrument industry, garnering about half of the total revenue in 2017, owing to highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 5.4% during the forecast period, owing to high prevalence of chronic diseases and rise in demand of minimally invasive surgery. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).
Torchbearers of the market
The key players analyzed in the report include De Soutter Medical Ltd., Peter Brasseler Holdings, LLC, Intrauma S.p.A., GEISTER Medizintechnik GmbH, and Ruijin Medical Instrument & Device Co., Ltd.
Web: https://www.alliedmarketresearch.com
SOURCE: Allied Market Research
0 Comments